Market Cap 3.28B
Revenue (ttm) 2.79B
Net Income (ttm) -116.89M
EPS (ttm) N/A
PE Ratio 15.36
Forward PE 14.77
Profit Margin -4.18%
Debt to Equity Ratio -21.93
Volume 2,067,600
Avg Vol 1,582,266
Day's Range N/A - N/A
Shares Out 314.08M
Stochastic %K 10%
Beta 1.18
Analysts Strong Sell
Price Target $12.50

Company Profile

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and r...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 908 947 3120
Fax: 908 947 3146
Address:
400 Crossing Boulevard, 3rd Floor, Bridgewater, United States
10sense
10sense Oct. 30 at 5:58 PM
$AMRX great numbers on this one this morning. I have no clue why it's down
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 30 at 12:38 PM
$AMRX (+3.2% pre) Amneal receives tentative FDA approval for generic asthma inhaler https://ooc.bz/l/82505
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 27 at 9:56 PM
Results $AMRX $AMRZ $AMSC $AMT $AMWD 🔥
0 · Reply
resistancebreakers
resistancebreakers Oct. 2 at 7:23 PM
$AMRX insider buys 🔥🪖🫡☝️
1 · Reply
Fishbull
Fishbull Oct. 1 at 11:11 PM
$AMRX Let’s see how far this will go now that 10$ has been crossed
0 · Reply
Mhollenbuy
Mhollenbuy Sep. 30 at 5:32 PM
0 · Reply
Fishbull
Fishbull Sep. 30 at 1:25 AM
$AMRX hoping it crosses 10$
0 · Reply
POV_NPC
POV_NPC Sep. 26 at 9:48 PM
$AMRX growth driver. This company is focused on expansion and is making the case for long term strength. https://finance.yahoo.com/news/amneal-announces-bla-submission-biosimilar-120000008.html
0 · Reply
sandford1
sandford1 Sep. 26 at 1:41 AM
$AMRX Does anyone know how Pfizer buying metesera pharma impact amneal contract with metesera.
1 · Reply
NyseDayTrader
NyseDayTrader Sep. 24 at 8:58 PM
0 · Reply
Latest News on AMRX
Amneal Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 6:00 AM EDT - 16 hours ago

Amneal Reports Third Quarter 2025 Financial Results


Amneal to Report Third Quarter 2025 Results on October 30, 2025

Sep 30, 2025, 4:05 PM EDT - 4 weeks ago

Amneal to Report Third Quarter 2025 Results on October 30, 2025


Amneal Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 6:00 AM EDT - 3 months ago

Amneal Reports Second Quarter 2025 Financial Results


Amneal to Report Second Quarter 2025 Results on August 5, 2025

Jul 9, 2025, 8:00 AM EDT - 4 months ago

Amneal to Report Second Quarter 2025 Results on August 5, 2025


Amneal to Participate at Upcoming Investor Conferences in June

May 29, 2025, 4:05 PM EDT - 5 months ago

Amneal to Participate at Upcoming Investor Conferences in June


US FDA approves Amneal's migraine treatment

May 15, 2025, 8:16 AM EDT - 6 months ago

US FDA approves Amneal's migraine treatment


Amneal Reports First Quarter 2025 Financial Results

May 2, 2025, 6:00 AM EDT - 6 months ago

Amneal Reports First Quarter 2025 Financial Results


Amneal to Report First Quarter 2025 Results on May 2, 2025

Apr 8, 2025, 4:05 PM EDT - 7 months ago

Amneal to Report First Quarter 2025 Results on May 2, 2025


Amneal to Participate at Upcoming Investor Conference

Mar 10, 2025, 4:05 PM EDT - 8 months ago

Amneal to Participate at Upcoming Investor Conference


Amneal to Participate at Upcoming Investor Conferences

Dec 4, 2024, 8:00 AM EST - 11 months ago

Amneal to Participate at Upcoming Investor Conferences


Amneal Reports Third Quarter 2024 Financial Results

Nov 8, 2024, 6:00 AM EST - 1 year ago

Amneal Reports Third Quarter 2024 Financial Results


Melina Kennedy Joins the LDI, Ltd. Board of Managers

Aug 20, 2024, 9:45 AM EDT - 1 year ago

Melina Kennedy Joins the LDI, Ltd. Board of Managers

WBTN


10sense
10sense Oct. 30 at 5:58 PM
$AMRX great numbers on this one this morning. I have no clue why it's down
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 30 at 12:38 PM
$AMRX (+3.2% pre) Amneal receives tentative FDA approval for generic asthma inhaler https://ooc.bz/l/82505
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 27 at 9:56 PM
Results $AMRX $AMRZ $AMSC $AMT $AMWD 🔥
0 · Reply
resistancebreakers
resistancebreakers Oct. 2 at 7:23 PM
$AMRX insider buys 🔥🪖🫡☝️
1 · Reply
Fishbull
Fishbull Oct. 1 at 11:11 PM
$AMRX Let’s see how far this will go now that 10$ has been crossed
0 · Reply
Mhollenbuy
Mhollenbuy Sep. 30 at 5:32 PM
0 · Reply
Fishbull
Fishbull Sep. 30 at 1:25 AM
$AMRX hoping it crosses 10$
0 · Reply
POV_NPC
POV_NPC Sep. 26 at 9:48 PM
$AMRX growth driver. This company is focused on expansion and is making the case for long term strength. https://finance.yahoo.com/news/amneal-announces-bla-submission-biosimilar-120000008.html
0 · Reply
sandford1
sandford1 Sep. 26 at 1:41 AM
$AMRX Does anyone know how Pfizer buying metesera pharma impact amneal contract with metesera.
1 · Reply
NyseDayTrader
NyseDayTrader Sep. 24 at 8:58 PM
0 · Reply
mikesterz7
mikesterz7 Sep. 24 at 12:48 AM
$AMRX The New Jersey-headquartered company said the most common adverse reaction associated with the use of eyedrops is conjunctival hyperemia or redness of the eye. The company expects the solution to be a key growth driver for its Affordable Medicines portfolio.
0 · Reply
prismmarketview
prismmarketview Sep. 23 at 6:31 PM
FDA approval: 3AmnealPharma (Nasdaq: $AMRX) wins ANDA for bimatoprost ophthalmic solution 0.01%, the generic equivalent of LUMIGAN®. Expands its Affordable Medicines portfolio, delivering lower-cost treatment for glaucoma & ocular hypertension patients. https://prismmarketview.com/fda-approves-amneals-generic-version-of-bimatoprost-ophthalmic-solution/
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 23 at 12:29 PM
Amneal Pharma Stock Rises On FDA Approval For Generic Version Of AbbVie’s Eyedrops $AMRX https://stocktwits.com/news/equity/markets/amneal-pharma-stock-rises-on-fda-approval-for-generic-version-of-abbvie-eyedrops/chDhHHIR35Q
0 · Reply
notreload_ai
notreload_ai Sep. 23 at 12:26 PM
$AMRX has received FDA approval for a generic eye drop (bimatoprost 0.01%) used to treat high eye pressure linked to glaucoma and ocular hypertension. https://notreload.xyz/amneal-generic-bimatoprost-ophthalmic-solution-fda-approved/
0 · Reply
ChristopherBrecher
ChristopherBrecher Sep. 22 at 6:25 PM
$AMRX Right now the SEC is "looking the other way" on insider trading. We can use that to our advantage by looking for unusual option activity. Here is one today.
0 · Reply
anachartanalyst
anachartanalyst Sep. 16 at 1:01 PM
$AMRX https://anachart.com/wp-content/uploads/ana_temp/1758027699_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Sep. 16 at 12:00 PM
JP Morgan has adjusted their stance on Amneal Pharmaceuticals ( $AMRX ), setting the rating to Overweight with a target price of 12 → 14.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Sep. 14 at 7:30 PM
$AMPX $AMRX scrabble bag it, both heading for $20 in due time
0 · Reply
mru01
mru01 Sep. 11 at 12:27 PM
$AMRX FDA approval
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 8 at 7:52 PM
$AMRX Going to 10
0 · Reply
BigSqueezeComing
BigSqueezeComing Sep. 8 at 7:52 PM
$AMRX loading up.
0 · Reply
sandford1
sandford1 Sep. 5 at 1:37 PM
$AMRX What is this fda warning letter for this company. Anyone know?
1 · Reply